These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

922 related items for PubMed ID: 19540640

  • 1. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH, CARDS Investigators.
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [Abstract] [Full Text] [Related]

  • 2. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators.
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [Abstract] [Full Text] [Related]

  • 3. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
    Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, TNT (Treating to New Targets) Investigators.
    J Am Coll Cardiol; 2008 Apr 15; 51(15):1448-54. PubMed ID: 18402899
    [Abstract] [Full Text] [Related]

  • 4. Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients.
    Sorof J, Berne C, Siewert-Delle A, Jørgensen L, Sager P, URANUS study investigators.
    Diabetes Res Clin Pract; 2006 Apr 15; 72(1):81-7. PubMed ID: 16246447
    [Abstract] [Full Text] [Related]

  • 5. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T, Matsuyama Y, Iimuro S, Umegaki H, Sakurai T, Araki A, Ohashi Y, Ito H, Japanese Elderly Diabetes Intervention Trial Research Group.
    Geriatr Gerontol Int; 2012 Apr 15; 12 Suppl 1():88-102. PubMed ID: 22435944
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).
    Knopp RH, d'Emden M, Smilde JG, Pocock SJ.
    Diabetes Care; 2006 Jul 15; 29(7):1478-85. PubMed ID: 16801565
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS, Poulter NR, Dahlof B, Wedel H, ASCOT Investigators.
    J Hypertens; 2009 May 15; 27(5):947-54. PubMed ID: 19318984
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G, Irish A, Chan D, Watts G.
    Am J Kidney Dis; 2007 Jun 15; 49(6):776-85. PubMed ID: 17533020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lessons learnt from the 4D trial.
    Wanner C, Krane V.
    Nephrol Ther; 2006 Feb 15; 2(1):3-7. PubMed ID: 16895709
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.
    Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP.
    Am J Kidney Dis; 2008 Dec 15; 52(6):1051-60. PubMed ID: 18706747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial.
    Pijls LT, de Vries H, van Eijk JT, Donker AJ.
    Eur J Clin Nutr; 2002 Dec 15; 56(12):1200-7. PubMed ID: 12494305
    [Abstract] [Full Text] [Related]

  • 20. The collaborative atorvastatin diabetes study: preliminary results.
    Owen OG.
    Int J Clin Pract; 2005 Jan 15; 59(1):121-3. PubMed ID: 15707477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.